Cesarean sections and delayed closure increase the risk of sepsis and length of stay in neonates with gastroschisis
Monday, November 2, 2015
: 9:30 a.m. - 9:50 a.m.
Background: Neonates with gastroschisis, a congenital birth defect of the abdominal wall, undergo primary or delayed closure following birth. To optimize management of neonates with gastroschisis we evaluated the risk of culture proven sepsis based upon the mode of delivery and the closure strategy. Additionally, we investigated the effect of sepsis and type of closure on length of stay (LOS). Methods: The records of neonates with gastroschisis and their mothers managed in two academic medical centers from 1999 to 2012 were reviewed (n=152). The mode of delivery was defined as: vaginally(V), cesarean section with labor(CS&L), and cesarean section(CS) without labor. The closure type was classified as: primary fascial closure (P/F) and initial silo closure with staged fascial closure (S). Primary outcome was culture proven sepsis and secondary outcome was LOS. Sepsis rates by mode of delivery and type of closure were assessed. Crude log-binomial risk ratios (RR) and 95% confidence intervals (CI) were reported for the presence of chlamydia, gonorrhea, genital herpes, and urinary tract infections. The effects of sepsis and mode of delivery and type of closure on LOS were assessed using multiple linear regression. Results: The mode of delivery was distributed as: 51.8%V, 25.6%CS&L, and 22.6%CS. The distribution of closure strategies was as follows: P/F=44 and S=108. Sepsis incidence was 2.5 times more likely in CS&L compared to V, RR=2.51(1.55-4.05). Sepsis rate in CS was not significantly increased compared to V, RR=1.50(0.82-2.77). Sepsis incidence was 83% higher in S compared to P/F, RR=1.83(1.02-3.30). The risk of sepsis was doubled among neonates delivered to mothers with chlamydia RR=2.07(1.30-3.30). LOS in neonates delivered by CS&L and CS were 15(-31 to 0.55) days and 6(-22 to 9) days shorter, respectively, compared to V. Neonatal sepsis increased LOS by 50(35 to 63) days compared to neonates without sepsis. An increase of 26(11.89, 39.99) days was observed for neonates with S compared to P/F, while sepsis increased LOS by 45(31.55, 58.07) days. Conclusion: A significant increase in risk of sepsis was observed for neonates with gastroschisis delivered by CS&L and a significant increase in both the risk of sepsis and LOS associated with S compared to P/F, but further investigations are warranted to elucidate these effects. This study and information can aid the development of neonatal and pediatric policies to support high-risk deliveries.
Administer health education strategies, interventions and programs
Basic medical science applied in public health
Clinical medicine applied in public health
Planning of health education strategies, interventions, and programs
Provision of health care to the public
Public health or related research
Discuss the importance of identifying high risk factors that can contribute to adverse effects in neonates with gastroschisis.
Explain the significance of educating and increasing awareness and knowledge in the population locally and globally about birth outcome in neonates with gastroschisis.
Discuss how studying the epidemiology of gastroschisis can provide further insight into current and up-to-date medical and non-medical policies.
Keyword(s): Birth Defects, Maternal and Child Health
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am a PhD student in Biology focusing on Perinatal Biology and investing the temporal, spatial, environmental, biological, social, epidemiological, and obstetric factors contributing to gastroschisis and negative pregnancy outcomes. I have my MPH with a concentration in Global Health with work related to community and minority health, cultural sensitivity and cross- cultural interactions.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.